Skip to main content
. Author manuscript; available in PMC: 2016 Apr 5.
Published in final edited form as: Gene Ther. 2008 Apr 10;15(18):1257–1270. doi: 10.1038/gt.2008.58

Figure 3.

Figure 3

In vivo efficacy of reovirus. Mel-888 xenograft tumours were established in athymic nude mice (eight per group). Tumours were treated with five daily intratumoural injections of either phosphate buffered saline (PBS) or ultraviolet (UV)-inactivated or live reovirus. Tumour growth and survival was monitored up to 70 days after injection. (a) Data represent the percentage of mice surviving over time following injection. (b) Tumour volume of individual mice (each represented by a single line) treated with either PBS or UV-inactivated or live reovirus.